The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study)

Some African countries are still reluctant to introduce the hepatitis B vaccine birth dose (HepB-BD) into their expanded program of immunization (EPI), partly because of logistical, economic, and cost information constraints. To assist decision-makers in these countries, we assessed the economic and...

Full description

Bibliographic Details
Main Authors: Andréa Gosset, Marie Libérée Nishimwe, Mamadou Yaya Diallo, Lucas Deroo, Aldiouma Diallo, El Hadji Ba, Patrizia Maria Carrieri, Cheikh Sokhna, Muriel Vray, Yusuke Shimakawa, Sylvie Boyer
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/5/521

Similar Items